NCT01648153 - Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

January 31, 2014

Conditions

Diabetes Mellitus

Interventions

BIOLOGICAL

GSK1070806

To investigate the efficacy and biomarker changes of GSK1070806 after 0.25mg/kg IV administration

OTHER

Placebo (saline)

To compare the efficacy and biomarker changes between placebo and active groups

BIOLOGICAL

GSK1070806

To investigate the efficacy and biomarker changes of GSK1070806 after 5mg/kg IV administration

Trial Locations (13)

GSK Investigational Site, Granada

GSK Investigational Site, Lleida

GSK Investigational Site, Madrid

GSK Investigational Site, Madrid

GSK Investigational Site, Málaga

GSK Investigational Site, Santander

GSK Investigational Site, Alzira/Valencia

GSK Investigational Site, Alicante

GSK Investigational Site, La Roca Del Valles (Barcelona)

GSK Investigational Site, Petrer, Alicante

GSK Investigational Site, Birmingham

GSK Investigational Site, Cambridge

GSK Investigational Site, Dundee